Cimetropium bromide
An antimuscarinic drug used in the treatment of gastrointestinal disorders
Cimetropium bromide | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Cimetropium bromide is a pharmaceutical drug classified as an antimuscarinic agent. It is primarily used in the management of gastrointestinal disorders, particularly those involving spasms of the smooth muscle in the gastrointestinal tract.
Pharmacology[edit | edit source]
Cimetropium bromide functions by blocking the action of acetylcholine on muscarinic receptors located on the smooth muscle cells of the gastrointestinal tract. This action leads to a reduction in muscle spasms and provides relief from pain and discomfort associated with conditions such as irritable bowel syndrome and spastic colon.
Mechanism of Action[edit | edit source]
The drug acts as a competitive antagonist at muscarinic receptors, which are a subtype of acetylcholine receptors. By inhibiting these receptors, cimetropium bromide decreases the motility and tone of the smooth muscles in the gastrointestinal tract, thereby alleviating symptoms of cramping and spasms.
Clinical Use[edit | edit source]
Cimetropium bromide is indicated for the treatment of various gastrointestinal conditions characterized by hypermotility and spasm. It is often prescribed for patients suffering from irritable bowel syndrome (IBS), where it helps to manage symptoms such as abdominal pain and discomfort.
Side Effects[edit | edit source]
As with other antimuscarinic agents, cimetropium bromide may cause side effects such as dry mouth, blurred vision, constipation, and urinary retention. These effects are due to the systemic anticholinergic activity of the drug.
Administration[edit | edit source]
Cimetropium bromide is typically administered orally in the form of tablets. The dosage and frequency depend on the severity of the condition being treated and the patient's response to the medication.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD